Cargando…

CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach

BACKGROUND: Recent studies have focused on the diagnostic and prognostic significance of CD24 and CD44 expression in human cancers. This study aimed to explore changes in CD44 and CD24 expression levels in patients with gastric cancer and to assess their prognostic values. METHODS: CD44 and CD24 exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Xueyuan, Cao, Donghui, Jin, MeiShan, Jia, Zhifang, Kong, Fei, Ma, Hongxi, Wang, Yinping, Jiang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175630/ https://www.ncbi.nlm.nih.gov/pubmed/25212506 http://dx.doi.org/10.1186/1471-230X-14-157

Ejemplares similares

Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer
por: Wu, Cheng-Lin, et al.
Publicado: (2015)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
por: Jiang, Jing, et al.
Publicado: (2013)

Polymorphism of DNA Methyltransferase 3b and Association with Development and Prognosis in Gastric Cancer
por: Wang, Chuan, et al.
Publicado: (2015)

CD44(+)CD24(−) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
por: Hurt, E M, et al.
Publicado: (2008)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Kong, Fei, et al.
Publicado: (2020)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
por: Si, Daolin, et al.
Publicado: (2020)

Long non-coding RNA polymorphisms on 8q24 are associated with the prognosis of gastric cancer in a Chinese population
por: Zhang, Yangyu, et al.
Publicado: (2020)

Utility of CD44/CD24 in the Outcome and Prognosis of Oral Squamous Cell Carcinoma: A Systematic Review
por: Poothakulath Krishnan, Reshma, et al.
Publicado: (2023)

CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
por: Moon, Yong Wha, et al.
Publicado: (2017)

Glomus tumor of the stomach: A case report
por: Wu, Menghui, et al.
Publicado: (2018)

Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017)

Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer
por: Yang, Na, et al.
Publicado: (2021)

Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma.
por: Joensuu, H., et al.
Publicado: (1993)

Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
por: Dong, Qiang, et al.
Publicado: (2019)

The CD44(+)/CD24(- )phenotype is enriched in basal-like breast tumors
por: Honeth, Gabriella, et al.
Publicado: (2008)

Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach
por: Jiang, Junjie, et al.
Publicado: (2022)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

Dynamic regulation of CD24 and the invasive, CD44(pos)CD24(neg )phenotype in breast cancer cell lines
por: Meyer, Matthew J, et al.
Publicado: (2009)

Cancer stem cell markers ALDH1 and CD44+/CD24– phenotype and their prognosis impact in invasive ductal carcinoma
por: Rabinovich, Iris, et al.
Publicado: (2018)

Combined neuroendocrine carcinoma and adenocarcinoma in the stomach: A case report
por: LI, SHOUZHEN, et al.
Publicado: (2014)

High ADAMTS18 expression is associated with poor prognosis in stomach adenocarcinoma
por: Jiang, Kaiyuan, et al.
Publicado: (2020)

CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549
por: Roudi, Raheleh, et al.
Publicado: (2013)

CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis
por: Liu, Shuangqing, et al.
Publicado: (2023)

Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
por: Jaggupilli, Appalaraju, et al.
Publicado: (2012)

CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
por: Yong, Ching-Shya, et al.
Publicado: (2012)

CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms
por: Soave, Danilo Figueiredo, et al.
Publicado: (2013)

Immunodetection of cells with a CD44+/CD24- phenotype in canine mammary neoplasms
por: Magalhães, Geórgia Modé, et al.
Publicado: (2013)

Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer
por: Zhang, Peng, et al.
Publicado: (2019)

Cobalt ferrite nanoparticle for the elimination of CD133+CD44(+) and CD44(+)CD24(−), in breast and skin cancer stem cells, using non-ionizing treatments
por: Khalili Najafabad, Bahareh, et al.
Publicado: (2023)

Polymorphisms of the DNA Methyltransferase 1 Gene Predict Survival of Gastric Cancer Patients Receiving Tumorectomy
por: Jia, Zhifang, et al.
Publicado: (2016)

CD44+ Circulating Tumor Endothelial Cells Indicate Poor Prognosis in Pancreatic Ductal Adenocarcinoma After Radical Surgery: A Pilot Study
por: Xing, Cheng, et al.
Publicado: (2021)

Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma.
por: Kim, Y. S., et al.
Publicado: (1997)

Comparative analysis of gene expression profiles of gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma
por: Song, Bin, et al.
Publicado: (2016)

CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016)

Expression of CDX2 in gastric cardia adenocarcinoma and its correlation with H. pylori and cell proliferation
por: Zhang, Ying, et al.
Publicado: (2016)

In Situ Identification of CD44+/CD24− Cancer Cells in Primary Human Breast Carcinomas
por: Perrone, Giuseppe, et al.
Publicado: (2012)

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis
por: Qiao, Xinbo, et al.
Publicado: (2021)

MZF1 Transcriptionally Activated MicroRNA-328-3p Suppresses the Malignancy of Stomach Adenocarcinoma via Inhibiting CD44
por: Qi, Zining, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nuqev4hp0ri57nv7mca54uhdoi